title: Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium.
abstract: Optimal therapy and prognosis of crescentic-IgA nephropathy (C-IgAN) are not known. Reported treatment options for C-IgAN include combination of corticosteroids and cyclophosphamide for 6 months. The role of mycophenolate sodium in C-IgAN is unknown. We report a case of C-IgAN that was successfully treated with combination immunosuppressive therapy.
authors: Department of Medicine, Division of Kidney Diseases and Hypertension, Long Island Jewish Medical Center and North Shore University Hospital, Hofstra Northwell School of Medicine, Great Neck, New York, USA.
authors: D
authors: D
authors: Bhandari
authors: Department of Medicine, Division of Kidney Diseases and Hypertension, Long Island Jewish Medical Center and North Shore University Hospital, Hofstra Northwell School of Medicine, Great Neck, New York, USA.
authors: K D
authors: KD
authors: Jhaveri
authors: Department of Medicine, Division of Kidney Diseases and Hypertension, Long Island Jewish Medical Center and North Shore University Hospital, Hofstra Northwell School of Medicine, Great Neck, New York, USA.
authors: H H
authors: HH
authors: Shah
keywords: Acute kidney injury; IgA nephropathy; crescentic nephropathy; glomerular diseases; mycophenolate sodium